BlackRock »

Travere Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Travere Therapeutics shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.3M 2.7M 0.86

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Travere Therapeutics

Wolverine Asset Management
D. E. Shaw & Co
Oaktree Capital Management
Graham Capital Management
Silverback Asset Management
Capstone Investment Advisors
Highbridge Capital Management
CNH Partners
Point72 Asset Management
Lazard Asset Management
Readystate Asset Management
Affinity Asset Advisors
Agf Management
Advent Capital Management
BlackRock

View all funds holding Travere Therapeutics